BARBARA LISCUM: Open Payments
NPI 1720084510 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$625 in 5 payments from 5 companies in 2025. Trend: 2023 $387 · 2024 $702 · 2025 $625
Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $137 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| KYOWA KIRIN, INC. | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $119 |
Products named: WAINUA, AUSTEDO XR, Descovy.
Industry payments across LA — which companies pay providers there.
